Source of Sangon Biotech

{{Infobox organisation | name = Sangon Biotech (Shanghai) Co., Ltd. | subtitle = Organisation | image = facility.svg | caption = Schematic synthesis and quality-control site. No image of this organisation's premises is available to this wiki. | Legal name = Sangon Biotech (Shanghai) Co., Ltd. | Trading name = SGN | Other designations = SGN Biotech, Sangon Biotech (Shanghai) <!-- Identity --> | Founded = 2004 | Headquarters = Shanghai, China | Industry = Research-compound supply | Shop domain = [https://sangonbio.com/ Visit SGN] <!-- Products and documentation --> | Product scope = peptides, SARMs, injectable oils and raw materials | Catalogue size = 350+ listings (self-reported) | Documentation = Batch certificate of analysis reported with orders | Independent reports = Submitted to this wiki by purchasers; see §Independent testing record <!-- PeptidePedia reception tally --> | Submissions = 751 to July 2026 | Evidence quality = '''Weak''' — self-selected, self-reported }} {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} {{primarysources|date=July 2026|talk=Scope: is this a peptide supplier article at all?}} '''Sangon Biotech (Shanghai) Co., Ltd.''' (trading as '''SGN'''; sangonbio.com) is a life-science reagent and peptide supplier trading as SGN from Shanghai, China, incorporated in 2004, whose catalogue spans research peptides alongside a broader range of laboratory reagents.{{r|registry,selfpub}} The organisation is one of twenty covered on PeptidePedia under [[Project:Vendor notability]]. Like the others, it distributes material labelled [[Research use only|for research use only]], which is '''not approved for human use''' in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.{{r|ruo}} This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by [[Janoshik Analytical]], [[Medutest]], [[PeptideMeter]] and [[VendorInvestigate]].{{r|tally}} == Corporate identity and history == Incorporated in 2004, the organisation has one of the longer histories among the entities covered here.{{r|registry}} Its catalogue is notably broader than the research-peptide sector norm, extending into general laboratory reagents, oligonucleotides and molecular-biology consumables, and its name appears in technical contexts unrelated to the research-compound trade.{{r|selfpub}} That breadth is the strongest element of its notability case and also the source of a scope question editors have discussed: an organisation whose peptide business is one line among many is not primarily a peptide supplier, and an article that treats it as one distorts what it is. == Distribution and dispatch == The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report. == Operations and documentation practice == Purchaser reports describe conventional practice for the peptide lines, with a batch certificate reporting purity and appearance, and water on some lots.{{r|reports}} Reagent-line reports describe documentation typical of the laboratory-supply trade — specification sheets and lot-specific certificates — which is a different documentary tradition from the research-compound sector and generally a more standardised one. No certification claim has been independently corroborated here.{{r|selfpub,gmp}} == Product range == | Class | Representative listings | Documentation reported | |---|---|---| | Research peptides | Incretin analogues, repair peptides | Certificate, purity; water sometimes | | Laboratory reagents | Buffers, enzymes, molecular-biology kits | Specification sheet, lot certificate | | Oligonucleotides | Synthesis to order | Certificate, sequence confirmation | | SARMs and raw materials | Bulk | Certificate, purity | The reagent and oligonucleotide lines place this organisation in a different category from most covered here. Its inclusion in this wiki's supplier articles reflects its peptide listings, not the whole of its business.{{r|selfpub}} == Independent testing record == Submitted reports on SGN peptide material to July 2026 are moderate in number. Reported [[Area percent purity|area percent]] figures have been high and consistent with accompanying certificates.{{r|reports}} Because the reagent business operates in a market with its own documentation conventions, purchasers have occasionally compared the two and found the reagent-line paperwork more standardised than the peptide-line paperwork.{{r|reports}} That comparison is within one organisation and is therefore more informative than a comparison across organisations, but it rests on a small number of reports. == Reception == The PeptidePedia tally records 751 self-reported submissions to July 2026. Recurring positive themes are catalogue breadth and documentation on the reagent lines; recurring complaints concern inconsistency between the two documentary traditions.{{r|tally}} Self-selected; reception rather than quality.{{r|tally}} === How this tally should be read === The reception figure above is a mean of self-reported submissions to PeptidePedia. It is '''weak evidence''' and is subject to three limitations that apply to every such figure on this wiki: * '''Self-selection.''' People who submit are not a sample of purchasers. Both satisfaction and dissatisfaction motivate reporting, in unknown proportions. * '''It measures reception, not quality.''' Packaging, communication and delivery are more visible to a purchaser than purity, and weigh accordingly. * '''It is not comparable across communities.''' Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.{{r|tally}} PeptidePedia does not rank suppliers and does not maintain a league table. The figures exist because omitting them would be a worse distortion than publishing them with their limitations stated.{{r|tally}} == Regulatory position and legal status == The organisation is a commercial entity registered in the People's Republic of China. Nothing in the available record indicates a manufacturing authorisation, marketing authorisation or pharmacopoeial registration in any jurisdiction, and none should be inferred from a registered business scope, which is a licensing fact and not a quality assurance.{{r|registry}} Material labelled [[Research use only|for research use only]] is outside the regulatory framework that governs medicines. Its identity, purity, sterility and [[Bacterial endotoxin test|endotoxin]] content are not assured by any regulator, and a [[Certificate of analysis|certificate of analysis]] issued by a supplier is a claim by that supplier rather than an independent finding.{{r|ruo,usp1503}} Import of such material for personal use is unlawful or restricted in many jurisdictions, and [[Customs seizure|seizure]] is a documented outcome. PeptidePedia describes the legal position and does not advise on it.{{r|ruo}} == Notability and coverage == This article exists because the organisation satisfies at least three of the five criteria at [[Project:Vendor notability]]. The available documentary base is: a company registration record; the organisation's own published material, usable only for what it states about itself; and third-party test reports submitted by purchasers.{{r|registry,selfpub,reports}} What is '''not''' available is independent coverage in a source unconnected with the organisation or its customers. That gap is characteristic of the sector rather than of this entity, and it constrains what a neutral article can say: capability, capacity, manufacturing arrangements and quality systems are not established here, and statements about them appear only as attributed claims.{{r|selfpub}} Two frameworks are named in this article only to say what has ''not'' been established against them: a quality-system claim is not a fact until assessed against the applicable good-manufacturing-practice framework,{{r|gmp}} and a testing laboratory's competence is a matter of accreditation to a recognised standard rather than of self-description.{{r|iso17025}} Neither assessment is available here for this organisation or for any other covered on this wiki. The article's talk page carries the notability discussion in full, including the standing question of whether entities with no distinguishing features warrant separate articles at all. == External links == * [https://sangonbio.com/ Visit SGN] == References == {{reflist}} <ref name="registry">National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.</ref> <ref name="selfpub">Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per [[Project:Verifiability]].</ref> <ref name="reports">Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See [[Blind sampling]].</ref> <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.</ref> <ref name="iso17025">ISO/IEC 17025:2017, ''General requirements for the competence of testing and calibration laboratories''. International Organization for Standardization.</ref> <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> == Further reading == * [[Project:Vendor notability]] — the criteria under which this article exists, and what supplier articles may not contain. * [[Project:Sourcing guidelines]] — how test reports and community tallies are cited on this wiki. == See also == * [[Certificate of analysis]] * [[Third-party testing]] * [[Area percent purity]] * [[Peptide content]] * [[Research use only]] * [[Peptide supply chain]] * [[Blind sampling]] {{DEFAULTSORT:Sangon Biotech}} [[Category:Peptide suppliers]] [[Category:Suppliers in China]] [[Category:Certificates of analysis]] [[Category:Testing methodology]]